Posts tagged CTIC


Stock Update (NASDAQ:CTIC): CTI BioPharma Corp Announces Positive Progress On Lead Programs

CTI BioPharma Corp (NASDAQ:CTIC) announced positive progress on its lead programs in addition to key …

Company Update (NASDAQ:CTIC): Here’s Why CTI BioPharma Corp Shares Are Soaring 18% Today

CTI BioPharma Corp (NASDAQ:CTIC) announced that the full clinical hold (February 2016) implemented by the …

Company Update (NASDAQ:CTIC): CTI BioPharma Corp Announces Retirement Of President And CEO

CTI BioPharma Corp (NASDAQ:CTIC) announced that James A. Bianco, M.D, CTI BioPharma’s President and Chief Executive …

Company Update (NASDAQ:CTIC): CTI BioPharma Corp Presented Long-Term Follow Up Data For Pacritinib At 2016 ASCO Annual Meeting

CTI BioPharma Corp (NASDAQ:CTIC) announced long-term safety and efficacy results from the pivotal Phase 3 …

Company Update (NASDAQ:CTIC): CTI BioPharma Corp Reports First Quarter 2016 Financial Results

CTI BioPharma Corp (NASDAQ:CTIC) reported financial results for the first quarter ended March 31, 2016. “We …

Company Update (NASDAQ:CTIC): CTI BioPharma Corp Presents Preclinical Data of Pacritinib at AACR Annual Meeting 2016

CTI BioPharma Corp (NASDAQ:CTIC) announced findings from an investigator-sponsored preclinical study indicating that pacritinib, an inhibitor …

Company Update (NASDAQ:CTIC): CTI BioPharma Corp Reports Fourth Quarter And Full Year 2015 Results

CTI BioPharma Corp (NASDAQ:CTIC) reported financial results for the fourth quarter and full year ended December …

Show More